Elevated adrenaline and increased alpha-adrenoceptor-mediated vasoconstriction in essential hypertension

Area of Science:

• Cardiovascular Physiology
• Hypertension Research
• Autonomic Nervous System Function

Background:

• Essential hypertension is characterized by elevated blood pressure without a clear secondary cause.
• Sympathetic nervous system activity plays a crucial role in regulating blood pressure.
• Adrenoceptors, specifically alpha and beta types, mediate the effects of catecholamines like adrenaline on cardiovascular function.

Purpose of the Study:

• To investigate the role of plasma adrenaline and adrenoceptor function in essential hypertension.
• To explore the relationship between adrenaline, heart rate, and vasodilator responses in hypertensive patients.
• To elucidate the contribution of alpha- and beta-adrenoceptor-mediated mechanisms to the pathophysiology of hypertension.

Main Methods:

• Measurement of plasma adrenaline levels in patients with essential hypertension and normotensive controls.
• Assessment of forearm circulation vasodilator response to postjunctional alpha 1-adrenoceptor blockade with prazosin.
• Correlation analysis between adrenaline levels, heart rate, and vasodilator responses.

Main Results:

• Plasma adrenaline levels were consistently higher in hypertensive patients compared to controls, irrespective of age.
• Adrenaline levels correlated positively with heart rate.
• The vasodilator response to prazosin was enhanced in hypertensive patients, suggesting greater alpha 1-adrenoceptor-mediated vasoconstriction.
• Beta-adrenoceptor-mediated responses were found to decrease with age and hypertension.

Conclusions:

• Elevated sympathetic activity and enhanced postjunctional alpha 1-adrenoceptor-mediated vasoconstriction are implicated in essential hypertension.
• Age-related decline in beta-adrenoceptor function may lead to unopposed alpha-adrenoceptor activity, contributing to hypertension.
• These findings may explain the progression of hypertension from an early high cardiac output phase to a later high peripheral resistance phase.